The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Boston Scientific Launches PROMUS® Elementâ„¢ and TAXUS® Elementâ„¢ Stent Systems in India

February 18, 2011 3:36 am | by Boston Scientific | News | Comments

Company's third-generation drug-eluting stents now available in rapidly growing market


MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors

February 18, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Feb. 18, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced the appointment of Scott R. Ward as Chairman of its Board of Directors. Steven A. Elms, the incumbent Chairman and an original venture capital investor in the Company, will step down from the...


Fujifilm's Synapse® Mobility Extends Imaging Reach

February 18, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

STAMFORD, Conn., Feb. 18, 2011 /- FUJIFILM Medical Systems U.S.A., Inc. will be showcasing Synapse® Mobility*, its zero footprint mobile application enabling remote access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based...


China Medical Technologies Reports Third Fiscal Quarter Financial Results

February 18, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

BEIJING, Feb. 18, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China-based advanced in-vitro diagnostic ("IVD") company, announced its unaudited financial results for the third fiscal quarter ended December 31, 2010 ("3Q...


Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV

February 18, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

CORK, Ireland, Feb. 18, 2011 /- Tibotec Pharmaceuticals announced today that two global, registrational phase 3 trials are recruiting patients to examine TMC435, its investigational hepatitis C protease inhibitor, in treatment-naive adults with chronic genotype 1 hepatitis C virus (HCV)....


Golden Meditech to Form Strategic Alliance with Long Bon International

February 18, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

TAIPEI, Feb. 18, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings ("Golden Meditech," 0801.HK, 910801.TW) and Long Bon International Co., Limited ("Long Bon International") today announced that the companies have entered into a memorandum of understanding (MOU) for strategic...


Australia to host IOF Regionals - 2nd Asia-Pacific Osteoporosis and Bone Meeting

February 17, 2011 11:34 pm | by International Osteoporosis Foundation | News | Comments

IOF is pleased to announce the 2nd Asia-Pacific Osteoporosis and Bone Meeting, to be held in conjunction with the Australian & New Zealand Bone & Mineral Society (ANZBMS) Annual Scientific Meeting and with the Japanese Bone and Mineral Research Society


Competing risks analysis highlights new targets in preventing ESRD and death of diabetics

February 17, 2011 9:32 pm | by EurekAlert | News | Comments

(University of Helsinki) Many patients with Type 1 diabetes and overt nephropathy develop End-Stage Renal Disease (ESRD) and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome. Now, the researchers have...


Stretching before a run does not prevent injury

February 17, 2011 7:34 pm | by EurekAlert | News | Comments

(American Academy of Orthopaedic Surgeons) Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.


ASU forms innovative international health care partnership

February 17, 2011 4:33 pm | by Arizona State University | News | Comments

ASU and Taiwan's Chang Gung University have formalized an agreement to establish an international Biosignatures Center aimed at the prevention, early detection, diagnosis, and treatment of cancer and other more


HealthSouth 4Q profit surges on tax benefit

February 17, 2011 1:45 pm | by The Associated Press | News | Comments

HealthSouth Corp., which provides inpatient rehabilitation services, said Thursday its fourth-quarter surged on a hefty income tax benefit.The company earned $772.7 million, or $7.16 per share, up from $32.1 million, or 35 cents per share, a year earlier. Revenue rose 7 percent to $520.7...

Chelsea Therapeutics offering $35 million in stock

February 17, 2011 12:45 pm | by The Associated Press | News | Comments

Chelsea Therapeutics International Ltd. said Thursday that it plans a public offering of $35 million in stock.Deutsche Bank Securities Inc. is acting as sole book-running manager.The company has about 41.9 million shares of common stock outstanding.Shares of Chelsea Therapeutics fell 16 cents,...

Leading Hong Kong Hospital Is Recipient and First to Order Two TomoHD(R) Treatment Systems Worldwide

February 17, 2011 11:45 am | by The Associated Press | News | Comments () —TomoTherapy Incorporated ( (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that it has shipped its 350th treatment system. The milestone unit is the first...

SME Honors Loyal Member with the 2011 Award of Merit

February 17, 2011 11:36 am | by Society of Manufacturing Engineers | News | Comments

DEARBORN, Mich., February 17, 2011 — The Society of Manufacturing Engineers (SME) announced today that it is recognizing Robert V. Petrach Jr., CMfgE, with the 2011 Award of Merit, for the contributions he has made to the his local chapter, affiliated chapters and the Society...

Drug Follows Melanoma Wherever It Goes

February 17, 2011 11:36 am | by Massachusetts Institute of Technology | News | Comments

Researchers are testing the safety of a nanoparticle that targets cancer cells.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.